Asia Pacific Point-of-Care Molecular Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product & Services (Assays & Kits, Instruments, and Services & Software), Technology [PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and Other Technologies], Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)

No. of Pages: 208    |    Report Code: TIPRE00026189    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Point-of-Care Molecular Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Point-of-Care Molecular Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
  • 5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Opportunities
  • 5.2.1 Rising R&D and Innovation in Point- of-Care Molecular Diagnostics
5.3 Future Trends
  • 5.3.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits Across Residential Setting
5.4 Impact of Drivers and Restraints

6. Asia Pacific Point-of-Care Molecular Diagnostics Market Regional Analysis

6.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Overview
6.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Point-of-Care Molecular Diagnostics Market Forecast Analysis

7. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis – by Product & Services

7.1 Assays & Kits
  • 7.1.1 Overview
  • 7.1.2 Assays & Kits: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Services & Software
  • 7.3.1 Overview
  • 7.3.2 Services & Software: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis – by Technology

8.1 PCR
  • 8.1.1 Overview
  • 8.1.2 PCR: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
  • 8.2.1 Overview
  • 8.2.2 Isothermal Nucleic Acid Amplification Technology: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Other Technologies
  • 8.3.1 Overview
  • 8.3.2 Other Technologies: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis – by Application

9.1 Infectious Diseases
  • 9.1.1 Overview
  • 9.1.2 Other Technologies: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Oncology
  • 9.2.1 Overview
  • 9.2.2 Other Technologies: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Hematology
  • 9.3.1 Overview
  • 9.3.2 Other Technologies: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Prenatal Testing
  • 9.4.1 Overview
  • 9.4.2 Other Technologies: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Endocrinology
  • 9.5.1 Overview
  • 9.5.2 Other Technologies: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Other Applications
  • 9.6.1 Overview
  • 9.6.2 Other Technologies: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Point-of-Care Molecular Diagnostics Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.1.2 China: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.1.3 China: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Application
  • 10.1.1.2 India: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.2.2 India: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.2.3 India: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Application
  • 10.1.1.3 Japan: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.3.2 Japan: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.3.3 Japan: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Application
  • 10.1.1.4 Australia: Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.4.2 Australia: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.4.3 Australia: Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Application
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Point-of-Care Molecular Diagnostics Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Point-of-Care Molecular Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 bioMérieux SA
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Danaher Corporation
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Enzo Biochem, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Abbott
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 binx health, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Meridian BioScience, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Biocartis
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Quidel Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Bio-Rad Laboratories, Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. bioMérieux SA
  2.  F. Hoffmann-La Roche Ltd.
  3. Danaher Corporation
  4.  Enzo Biochem, Inc.
  5. Abbott
  6. binx health, Inc.
  7. Meridian BioScience, Inc.
  8. Biocartis
  9. Quidel Corporation
  10. Bio-Rad Laboratories, Inc.
asia-pacific-point-of-care-molecular-diagnostics-market